This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Synerkine Pharma B.v.. Active years: 2022-2025.
Company Filing History:
Years Active: 2022-2025
Title: Judith Prado Sanchez: Innovator in Fusion Protein Technology
Introduction
Judith Prado Sanchez is a prominent inventor based in Utrecht, Netherlands. She has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. With a total of 2 patents, her work focuses on innovative solutions for medical conditions characterized by pain and neuro-inflammation.
Latest Patents
One of her latest patents involves a fusion protein comprising interleukin 13 and a regulatory cytokine. This invention includes a nucleic acid molecule encoding the fusion protein, a vector containing this nucleic acid, and a host cell that incorporates the nucleic acid or vector. The fusion protein or a gene therapy vector encoding it may be utilized in the prevention or treatment of conditions such as pathological pain, chronic pain, neuro-inflammation, and neurodegeneration.
Career Highlights
Judith is currently associated with Synerkine Pharma B.V., where she continues to advance her research and development efforts. Her innovative work has the potential to significantly impact therapeutic approaches in the medical field.
Collaborations
Judith collaborates with notable colleagues, including Niels Eijkelkamp and Cornelis Erik Hack, who contribute to her research endeavors.
Conclusion
Judith Prado Sanchez exemplifies the spirit of innovation in biotechnology through her groundbreaking work on fusion proteins. Her contributions are paving the way for new treatments in the medical field.